These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34276085)

  • 1. Diabetes and Covid-19: Clinical implications and novel management strategies.
    D'Arcy R; Courtney CH
    Ulster Med J; 2021 May; 90(2):81-85. PubMed ID: 34276085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement.
    Malek M; Hosseinpanah F; Aghaei Meybodi HR; Jahed SA; Hadaegh F; Sharghi S; Esteghamati A; Khamseh ME
    Arch Iran Med; 2020 Aug; 23(8):564-567. PubMed ID: 32894970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: COVID-19 in patients with diabetes.
    Hill MA; Mantzoros C; Sowers JR
    Metabolism; 2020 Jun; 107():154217. PubMed ID: 32220611
    [No Abstract]   [Full Text] [Related]  

  • 5. PERSEVERE OR PERIL: DIABETES CARE IN TIMES OF COVID-19.
    Barengolts E
    Endocr Pract; 2020 Jun; 26(6):688-690. PubMed ID: 32568569
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.
    Gómez Antúnez M; Muiño Míguez A; Bendala Estrada AD; Maestro de la Calle G; Monge Monge D; Boixeda R; Ena J; Mella Pérez C; Anton Santos JM; Lumbreras Bermejo C;
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3433-3445. PubMed ID: 33447021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.
    Singh AK; Khunti K
    Diabetes Res Clin Pract; 2020 Jul; 165():108266. PubMed ID: 32533989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucovigilance in COVID-19.
    Lamptey R; Ahomagnon S; Acheampong F; Kalra S
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
    Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
    Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID 19 could trigger global diabetes burden - A hypothesis.
    Mukherjee S; Banerjee O; Singh S; Maji BK
    Diabetes Metab Syndr; 2020; 14(5):963-964. PubMed ID: 32604015
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.
    Palermo NE; Sadhu AR; McDonnell ME
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32556147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.
    Angelidi AM; Belanger MJ; Mantzoros CS
    Metabolism; 2020 Jun; 107():154245. PubMed ID: 32320742
    [No Abstract]   [Full Text] [Related]  

  • 14. Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic.
    Pasquel FJ; Umpierrez GE
    J Diabetes Sci Technol; 2020 Jul; 14(4):705-707. PubMed ID: 32370606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks.
    Gujral UP; Johnson L; Nielsen J; Vellanki P; Haw JS; Davis GM; Weber MB; Pasquel FJ
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32690631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between insulin growth factor 1 and survival after SARS-CoV-2(COVID 19) infection in elderly kidney transplant recipients.
    Soliman AR; Sadek KM
    Ren Fail; 2021 Dec; 43(1):388-390. PubMed ID: 33627041
    [No Abstract]   [Full Text] [Related]  

  • 17. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.
    Zhou J; Tan J
    Metabolism; 2020 Jun; 107():154216. PubMed ID: 32220612
    [No Abstract]   [Full Text] [Related]  

  • 19. The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic.
    Jendle J
    J Diabetes Sci Technol; 2020 Jul; 14(4):739-740. PubMed ID: 32375494
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.